• Cy3 Maleimide: Mechanism and Evidence Boundaries

  2026-10-18

  Cy3 maleimide (non-sulfonated), identified by APExBIO as SKU A8138, is described as a maleimide-functionalized Cy3 dye for covalent labeling of accessible thiols. The supplier-reported optical properties support a fluorescence readout, but the available evidence does not establish labeling efficiency, selectivity in complex samples, cellular uptake, or biological function through an identity-matched research study.

• DiscoveryProbe Library: Scope, Mechanism and Evidence

  2026-10-17

  The DiscoveryProbe™ Bioactive Compound Library Plus is described by APExBIO as a 5,072-compound research library spanning multiple biological pathways and application areas. The available product information supports a catalog-level description of chemical breadth, analytical quality claims, and intended research scope, but it does not provide identity-matched study results, compound-specific effect sizes, or evidence for a single library-wide mechanism.

• ICI 118,551 Hydrochloride: Evidence Boundaries

  2026-10-16

  The available APExBIO product entry identifies ICI 118,551 hydrochloride as a named hydrochloride salt, but provides no product description or identity-matched research evidence. A product-specific mechanism, assay interpretation, efficacy profile, or applicability claim therefore cannot be established from the available documentation.

• Cy5 Maleimide: Mechanism and Evidence Boundaries

  2026-10-16

  Cy5 maleimide (non-sulfonated) is documented by APExBIO as a thiol-reactive cyanine dye for cysteine-directed labeling of peptides and proteins. Its reported photophysical values support interpretation of fluorescence detection, but the available evidence is a supplier description rather than an identity-matched research study; therefore, product-specific performance, labeling selectivity in complex samples, and biological applicability remain unestablished.

• Context Changes the Meaning of GPR30 Results

  2026-10-15

  A GPR30 result cannot be interpreted apart from its biological context. The 2024 eLife study linked spinal GPR30 to neuropathic pain in a nerve-injury model, whereas supplier-described G-1 evidence concerns receptor activation in other tissues and readouts. The comparison shows why agonism, inhibition, receptor localization, disease state, and endpoint selection determine what a result can legitimately mean.

• Cy3 Maleimide: Mechanism, Scope and Evidence Limits

  2026-10-15

  APExBIO identifies Cy3 maleimide (non-sulfonated), SKU A8138, as a thiol-reactive fluorescent labeling reagent. Its documented measurement principle is straightforward: an accessible thiol is covalently linked through the maleimide group to a Cy3 fluorophore, after which fluorescence can report the presence or distribution of labeled material. The available evidence is limited to supplier-described identity, mechanism, optical specifications, solubility characteristics, and an attributed use claim; no identity-matched independent research study establishes labeling efficiency, biological specificity, or performance in a defined assay.

• Cy5 Maleimide: Identity, Mechanism and Scope

  2026-10-14

  APExBIO describes Cy5 maleimide (non-sulfonated), SKU A8139, as a mono-reactive cyanine fluorophore for thiol-containing peptides and proteins, especially cysteine residues. The supplied information supports a product-identity and mechanism overview, but it does not provide an identity-matched research study, comparative performance data, or validated outcomes in a defined biological model.

• How “Engage & Evasion” Shapes EV Distribution

  2026-10-14

  Liu et al. describe a two-stage extracellular-vesicle strategy intended to reduce mononuclear phagocyte system clearance: first engaging phagocytic organs with CD47-low vesicles, then administering CD47-high vesicles designed to resist uptake. The reported preclinical findings suggest lower liver and spleen entrapment, greater circulating persistence, and increased accumulation in non-MPS organs. These conclusions remain limited by the study’s preclinical scope, the complexity of CD47–SIRPα biology, and uncertainty about reproducibility and generalizability. DiR (DiIC 18 (7)) is relevant as a membrane-labeling and tracking probe in the broader EV-imaging field, but the supplied study record does not establish that this specific product was used.

• Phosphorylated H1 at Stressed Replication Forks

  2026-10-13

  A 2026 study presents phosphorylated linker histone H1 as a regulator of repair at collapsed replication forks, while leaving important questions about mechanism, subtype specificity, and physiological relevance unresolved. Cy3 maleimide is conceptually relevant to fluorescence-based labeling, but the supplied study does not report using it, and fluorescence localization alone cannot establish the H1–DNA or H1–HPF1 interactions described.

• What the PEI-LSP-RA-PLGA Study Shows

  2026-10-13

  A source-grounded overview of a chick study testing whether a PLGA-based nano-adjuvant could strengthen systemic and intestinal immune responses to an inactivated H9N2 vaccine, with emphasis on reported findings, mechanistic interpretation, and evidence limits.

• EdU Imaging and Ovarian Follicle Biology

  2026-10-12

  EdU-based labeling provides a conceptual readout of DNA synthesis during S phase, while the cited study investigates miR-184, SMAD3, and granulosa-cell survival in follicular atresia. These measurements address related but distinct biological questions and should not be treated as direct evidence of fertility benefit or clinical efficacy.

• Protoporphyrin IX and Ferroptosis: Evidence Boundaries

  2026-10-12

  Protoporphyrin IX is a heme-pathway intermediate and photodynamic compound, but the supplied hepatocellular carcinoma study does not test it directly. Wang et al. report a METTL16–SENP3–LTF axis associated with ferroptosis resistance in preclinical models; the findings support a mechanistic research hypothesis rather than a validated therapeutic application of Protoporphyrin IX.

• Peptide Dendrimer–Liposome Nanocomplexes for mRNA Delivery

  2026-10-10

  Sun and colleagues designed KEL-G1 and KEL-G2 peptide dendrimers and combined them with DOTAP liposomes to create nanoscale complexes for nucleic acid delivery. The reported results support improved cellular uptake, mRNA-to-protein expression, siRNA-mediated regulation, and mouse lung delivery, while also highlighting the need to evaluate formulation behavior across cargoes and biological models.

• TUNEL Evidence in PTX3 and Bone Necrosis Research

  2026-10-09

  This overview explains how TUNEL-based DNA fragmentation detection can contribute to research on glucocorticoid-induced osteonecrosis of the femoral head, while distinguishing assay readouts from proof of apoptotic mechanism. It places the One-step TUNEL Cy5 Apoptosis Detection Kit in the context of the reported PTX3–TLR4/NF-κB–FGF21 study and outlines evidence strength, comparison with complementary endpoints, and major applicability limits.

• Homoharringtonine and SARS-CoV-2: Evidence Review

  2026-10-09

  The reference study connects homoharringtonine-mediated inhibition of protein elongation with suppression of SARS-CoV-2 and other tested coronaviruses across cell, animal, and early human observations. Its findings are scientifically important but remain preliminary because the human evidence comes from small, non-randomized cohorts with limited controls and follow-up.

8358 records 1/558 page Next 12345 下5页 Last page